Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Khamashta

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
Lupus|August 11, 2006
European attempts to set guidelines for improving diagnostics of autoimmune rheumatic disordersA Wiik, R Cervera, M Haass, et al.
Lupus|November 24, 1999
Assessing disease activity in SLE patients during pregnancyJ P Buyon, K C Kalunian, R Ramsey-Goldman, et al.
Lupus|August 2, 2003
Prophylaxis of the antiphospholipid syndrome: a consensus reportD Alarcón-Segovia, M C Boffa, W Branch, et al.
Lupus|August 2, 2003
Stroke and the antiphospholipid syndrome: consensus meeting Taormina 2002R L Brey, J Chapman, S R Levine, et al.
Lupus|June 3, 2016
Autoantibodies to domain 1 of beta 2 glycoprotein I determined using a novel chemiluminescence immunoassay demonstrate association with thrombosis in patients with antiphospholipid syndromeM Mahler, R Albesa, N Zohoury, et al.
Annals of the Rheumatic Diseases|March 1, 1991
Anticardiolipin antibodies in patients from Malaysia with systemic lupus erythematosusH W Jones, R Ireland, G Senaldi, et al.
Clinical and Experimental Rheumatology|July 1, 1992
Antiphospholipid antibodies cross-reacting with erythrocyte membranes. A case reportN Del Papa, P L Meroni, W Barcellini, et al.
Clinical and Experimental Immunology|November 1, 1988
Relationship between anti-cardiolipin and anti-endothelial cell antibodies in systemic lupus erythematosusA Vismara, P L Meroni, A Tincani, et al.
Journal of Neurology|October 1, 1992
Gadolinium-enhanced magnetic resonance imaging of the central nervous system in systemic lupus erythematosusD H Miller, N Buchanan, G Barker, et al.
Journal of Thrombosis and Haemostasis : JTH|August 20, 2016
Rivaroxaban limits complement activation compared with warfarin in antiphospholipid syndrome patients with venous thromboembolismD R J Arachchillage, I J Mackie, M Efthymiou, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Lupus|August 11, 2006
European attempts to set guidelines for improving diagnostics of autoimmune rheumatic disordersA Wiik, R Cervera, M Haass, et al.
Lupus|November 24, 1999
Assessing disease activity in SLE patients during pregnancyJ P Buyon, K C Kalunian, R Ramsey-Goldman, et al.
Lupus|August 2, 2003
Prophylaxis of the antiphospholipid syndrome: a consensus reportD Alarcón-Segovia, M C Boffa, W Branch, et al.
Lupus|August 2, 2003
Stroke and the antiphospholipid syndrome: consensus meeting Taormina 2002R L Brey, J Chapman, S R Levine, et al.
Lupus|June 3, 2016
Autoantibodies to domain 1 of beta 2 glycoprotein I determined using a novel chemiluminescence immunoassay demonstrate association with thrombosis in patients with antiphospholipid syndromeM Mahler, R Albesa, N Zohoury, et al.
Annals of the Rheumatic Diseases|March 1, 1991
Anticardiolipin antibodies in patients from Malaysia with systemic lupus erythematosusH W Jones, R Ireland, G Senaldi, et al.
Clinical and Experimental Rheumatology|July 1, 1992
Antiphospholipid antibodies cross-reacting with erythrocyte membranes. A case reportN Del Papa, P L Meroni, W Barcellini, et al.
Clinical and Experimental Immunology|November 1, 1988
Relationship between anti-cardiolipin and anti-endothelial cell antibodies in systemic lupus erythematosusA Vismara, P L Meroni, A Tincani, et al.
Journal of Neurology|October 1, 1992
Gadolinium-enhanced magnetic resonance imaging of the central nervous system in systemic lupus erythematosusD H Miller, N Buchanan, G Barker, et al.
Journal of Thrombosis and Haemostasis : JTH|August 20, 2016
Rivaroxaban limits complement activation compared with warfarin in antiphospholipid syndrome patients with venous thromboembolismD R J Arachchillage, I J Mackie, M Efthymiou, et al.
Pageof 9